Determining Risk in Pediatric Research with No Prospect of Direct Benefit: Time for a National Consensus on the Interpretation of Federal Regulations

By Fisher Celia   Kornetsky Susan   Prentice Ernest  

American Journal of Bioethics, Vol. 7, Iss. 3, 2007-03 ,pp. : 5-10

Routledge Ltd

Access to resources Recommend Favorite

When Is a Genetic Test Suitable for Prime Time? Predicting the Risk of Prostate Cancer as a Case-Example

By  

Public Health Genomics, Vol. 13, Iss. 1, 2009-05 ,pp. : 55-62

Karger

Access to resources Recommend Favorite

The Role of Controversial Research in the IRB's Risk/Benefit Analysis

By Lunstroth John  

American Journal of Bioethics, Vol. 11, Iss. 5, 2011-05 ,pp. : 14-16

Routledge Ltd

Access to resources Recommend Favorite

Regulating “Higher Risk, No Direct Benefit” Studies in Minors

By Westra Anna   Wit Jan   Sukhai Ram   de Beaufort Inez  

American Journal of Bioethics, Vol. 11, Iss. 6, 2011-06 ,pp. : 29-31

Routledge Ltd

Access to resources Recommend Favorite

Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing

By  

Public Health Genomics, Vol. 14, Iss. 2, 2010-04 ,pp. : 59-67

Karger

Access to resources Recommend Favorite